Ticker
NVCRCompany Name
NOVOCURE LTDSector
HealthcareIndustry
Medical DevicesExchange
NASDAQ| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -44.68M | -7.09% | $ 630.16M |
| 3/31/2025 | $ -30.46M | -4.9% | $ 621.71M |
| 12/31/2024 | $ -26.37M | -4.36% | $ 605.22M |
| 9/30/2024 | $ -37.48M | -6.49% | $ 577.74M |
| 6/30/2024 | $ -67.17M | -12.21% | $ 549.96M |
| 3/31/2024 | $ -88.18M | -16.78% | $ 525.66M |
| 12/31/2023 | $ -73.34M | -14.4% | $ 509.34M |
| 9/30/2023 | $ -62.48M | -12.4% | $ 503.98M |
| 6/30/2023 | $ -20.75M | -4.09% | $ 507.66M |
| 3/31/2023 | $ 17.75M | 3.4% | $ 522.48M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF % OCF % for NOVOCURE LTD is calculated as follows: CF - Operations [ $ 52.63M ] / Revenues [ $ 449.65M ]
(=) OCF % [ 11.7% ] Minimum
Mar 31, 2024
Maximum
Jun 30, 2021
Average
Median
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.31% |
| median | 12.65% |
| std | 21.13% |